Here, using a combination of a human iPSC-based model and Dp16 mice, we demonstrate that hyperactivation of IFN signaling downstream of increased dosage of IFNR genes downregulates canonical Wnt signaling and leads to cardiogenic dysregulation in DS. This evidence concerns the gene IFNA1 and Dravet syndrome.